Results 91 to 100 of about 3,822 (260)
Platelet transfusion: basic aspects
Swiss Medical Weekly, 2013 Platelet transfusions have been shown to prevent major haemorrhage and improve survival in thrombocytopenic patients. Since then, advances in the preparation of platelet components, including the introduction of pathogen reduction techniques, have ...
Andreas Holbro +3 more
doaj +1 more source
Diagnostic tool for Glanzmann\u27s thrombasthenia clinicopathologic spectrum [PDF]
, 2008 OBJECTIVE: To platelet aggregometry and describe the clinical spectrum of Glanzmann\u27s thrombasthenia diagnosed by platelet aggregometry. STUDY DESIGN: A case-series.
Adil, Salman +5 more
core +1 more source
Platelet kinetics after slow versus standard transfusions: A pilot study [PDF]
, 2011 Background. Platelet transfusion is required in the acute phase of some thrombocytopenic disorders in order to prevent potentially dangerous hemorrhages.
Abbas Habibi +18 more
core +2 more sources
American Journal of Hematology, Volume 101, Issue 3, Page 467-476, March 2026.ABSTRACT Non‐severe aplastic anemia (NSAA) is a heterogeneous bone marrow failure syndrome with limited standardized treatment options. Cyclosporine A (CsA) monotherapy often yields suboptimal responses, highlighting an unmet clinical need for more effective therapies.
Lele Zhang +18 more
wiley +1 more source
Revista Brasileira de Hematologia e Hemoterapia, 2010 Despite major advances in Brazilian blood transfusion therapy with a growing number of scientific publications, an increased number of repeat donors and a decline in serological ineligibility, a lack of conformity in the application of pre-transfusion ...
Aline A. Ferreira +3 more
doaj +1 more source
MedComm – Oncology, Volume 5, Issue 1, March 2026.Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang +7 more
wiley +1 more source
Frontiers in OncologyThe platelet human leucocyte antigen (HLA) gene bank contains the genetic information of HLA loci in a large number of blood donors. Currently, the most effective treatment for platelet transfusion refractoriness (PTR) is to evaluate the probability of ...
Xiang Gao +5 more
doaj +1 more source
Cell and Gene Therapy in Equine Ocular Disease
Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young +2 more
wiley +1 more source
Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia [PDF]
, 1990 DJ Christie +3 more
openalex +3 more sources
Smjernice Hrvatskog društva za hematologiju i transfuzijsku medicinu u dijagnostičko-terapijskom postupku za trombocitopeniju izazvanu heparinom (HIT) [Croatian Society for Haematology and Transfusion Medicine Guidelines on the diagnosis and management of heparin induced thrombocytopenia (HIT)] [PDF]
, 2012 Heparin induced thrombocytopenia (HIT) is a serious complication of heparin administration. In the last decade, this clinical syndrome has come into the focus of interest, primarily because of the severe thromboembolic complications that may lead to ...
Bošnjak, Bojana +15 more
core